XBI
SPDR Biotech ETFNYSEARCA
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Sat, Nov. 12, 4:43 PM
    • Barron's speaks with several prominent money managers.
    • They are hopeful that Donald Trump will enact pro-growth tax and fiscal-stimulus policies, while avoiding overly protectionist measures.
    • Even though biotech stocks have already rallied 10%, fund manager Arun Daniel believes that the benefits of a Trump administration on the bottom lines of biotech and drug companies are not yet fully priced in.  ETFs: IBB, XBI, BIB, BBH, FBT, HQL, PBE, BIS, LABU, BBC, BBP, CNCR, LABD, UBIO, ARKG, ZBIO, LABS
    • He's also bullish on stocks leveraged to government-backed infrastructure spending, his favorites being Jacobs Engineering (NYSE:JEC) and Martin Marietta Materials (NYSE:MLM).
    • Some companies will likely be allowed to repatriate billions of dollars of profits at a low tax rate. Major beneficiaries could include Nike (NYSE:NKE), Procter & Gamble (NYSE:PG), Caterpillar (NYSE:CAT), Visa (NYSE:V) and Mastercard (NYSE:MA).
    • Neuberger Berman's Joseph Amato says that a Trump administration will be better for stocks than bonds. "If [Trump] takes a measured approach and gets some level of concessions for U.S. workers, the trade concerns may be much ado about nothing," Amato says. "But that's a big if."
    | Sat, Nov. 12, 4:43 PM | 211 Comments
  • Wed, Nov. 9, 2:20 AM
    • Regardless of election calls tonight -- Donald Trump is reported to have 265 of a needed 270 electoral votes, to Hillary Clinton's 218 -- Clinton campaign chair John Podesta works to send her rally home, saying Clinton won't concede any election tonight: "We're not gonna have anything more to say tonight," Podesta says, adding "she is not done yet."
    • There are still several states counting, he says -- though Trump is quite close to the needed count.
    • Meanwhile, Jefferies Group looks ahead to the almost certain Trump presidency and says the most underrated theme is "the slashing of the corporate tax rate and the end of gridlock."
    • It means a knee-jerk drop in the dollar, the firm says -- the euro's now up 1.6% against the greenback, which is off 2.7% against yen -- and a fall in indexes. But dollar weakness will help much of the S&P 500, it says, considering the 35-40% of revenues that come from overseas.
    • "Sentiment toward the healthcare sector ought to swing initially away from draconian fears over drug pricing," the report from Sean Darby and team says. They're also "modestly bullish" on transports, with better growth prospects.
    • The main risk, Jefferies says, is "monetary policy uncertainty and unwinding tight credit spreads."
    • Healthcare ETFs: XBI, IBB. Transport ETFs: IYT, XTN, FTXR
    • Broad market ETFs: SPY, QQQ, DIA, SH, SSO, VOO, SDS, IVV, SPXU, TQQQ, UPRO, PSQ, SPXL, RSP, SPXS, SQQQ, QID, DOG, QLD, DXD, UDOW, RWL, SDOW, VFINX, EPS, DDM, QQEW, QQQE, SPLX, SFLA, QQXT, SPUU, SPXE, LLSP, UDPIX, OTPIX, RYARX, SPXN, SPDN, SPXT, SPXV, TALL.
    • #Election2016
    | Wed, Nov. 9, 2:20 AM | 27 Comments
  • Tue, Nov. 8, 8:58 PM
    | Tue, Nov. 8, 8:58 PM | 8 Comments
  • Thu, Nov. 3, 2:57 PM
    | Thu, Nov. 3, 2:57 PM | 225 Comments
  • Fri, Sep. 16, 3:27 PM
    • SPDR Russell 3000 ETF (NYSEARCA:THRK) - $0.7731. 30-Day Sec yield of 1.88%.
    • SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) - $0.1210. 30-Day Sec yield of 0.86%.
    • SPDR S&P Biotech ETF (NYSEARCA:XBI) - $0.0311. 30-Day Sec yield of 0.19%.
    • SPDR S&P Oil & Gas Equipment & Services ETF (NYSEARCA:XES) - $0.0276. 30-Day Sec yield of 1.38%.
    • SPDR S&P Homebuilders ETF (NYSEARCA:XHB) - $0.0510. 30-Day Sec yield of 0.60%.
    • SPDR S&P Healthcare Services ETF (NYSEARCA:XHS) - $0.0436. 30-Day Sec yield of 0.34%.
    • SPDR S&P Metals & Mining ETF (NYSEARCA:XME) - $0.0735. 30-Day Sec yield of 1.16%.
    • SPDR S&P Oil & Gas Exploration & Production ETF (NYSEARCA:XOP) - $0.0808. 30-Day Sec yield of 1.01%.
    • Payable Sept. 26; for shareholders of record Sept. 20; ex-div Sept. 16. 30-Day SEC yield as of 9/15/2016.
    | Fri, Sep. 16, 3:27 PM
  • Fri, Jun. 17, 7:12 PM
    • SPDR S&P 600 Small Cap ETF (NYSEARCA:SLY) $0.3529. 30-Day Sec yield of 1.36%.
    • SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG$0.5121. 30-Day Sec yield of 1.08%.
    • SPDR S&P 600 Small Cap Value ETF (NYSEARCA:SLYV$0.3926. 30-Day Sec yield of 1.64%.
    • SPDR S&P 500 Small Cap Growth ETF (NYSEARCA:SPYG$0.3892. 30-Day Sec yield of 1.48%.
    • SPDR S&P 500 Value ETF (NYSEARCA:SPYV$0.6250. 30-Day Sec yield of 2.52%.
    • SPDR Russell 3000 ETF (NYSEARCA:THRK$0.7799. 30-Day Sec yield of 1.96%.
    • SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR$0.1101. 30-Day Sec yield of 0.74%.
    • SPDR S&P Biotech ETF (NYSEARCA:XBI$0.0455. 30-Day Sec yield of 0.20%.
    • SPDR S&P Oil & Gas Equipment & Services ETF (NYSEARCA:XES$0.0314. 30-Day Sec yield of 1.73%.
    • SPDR S&P Homebuilders ETF (NYSEARCA:XHB$0.0505. 30-Day Sec yield of 0.59%.
    • Payable June 27; for shareholders of record June 21; ex-div June 17. 30-Day Sec yield as on 6/16/16.
    | Fri, Jun. 17, 7:12 PM
  • Tue, Jun. 14, 7:36 AM
  • Thu, Apr. 14, 3:58 AM
    | Thu, Apr. 14, 3:58 AM | 7 Comments
  • Fri, Mar. 18, 3:16 PM
    • SPDR S&P Biotech ETF (NYSEARCA:XBI) - quarterly distribution of $0.0578. 30-Day Sec yield of 0.78% (as of 3/16/2016).
    • SPDR S&P Oil & Gas Equipment & Services ETF (NYSEARCA:XES) - quarterly distribution of $0.0620. 30-Day Sec yield of 2.53% (as of 3/16/2016).
    • SPDR S&P Homebuilders ETF (NYSEARCA:XHB) - quarterly distribution of $0.0521. 30-Day Sec yield of 0.64% (as of 3/16/2016).
    • SPDR S&P Healthcare Services ETF (NYSEARCA:XHS) - quarterly distribution of $0.0238. 30-Day Sec yield of 0.29% (as of 3/16/2016).
    • SPDR S&P Metals & Mining ETF (NYSEARCA:XME) - quarterly distribution of $0.0889. 30-Day Sec yield of 2.28% (as of 3/16/2016).
    • SPDR S&P Oil & Gas Exploration & Production ETF (NYSEARCA:XOP) - quarterly distribution of $0.0859. 30-Day Sec yield of 1.51% (as of 3/16/2016).
    • SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - quarterly distribution of $0.0266. 30-Day Sec yield of 0.72% (as of 3/16/2016).
    • SPDR S&P Retail ETF (NYSEARCA:XRT) - quarterly distribution of $0.1520. 30-Day Sec yield of 1.17% (as of 3/16/2016).
    • SPDR S&P Semiconductor ETF (NYSEARCA:XSD) - quarterly distribution of $0.0519. 30-Day Sec yield of 0.65% (as of 3/16/2016).
    • SPDR S&P Software & Services ETF (NYSEARCA:XSW) - quarterly distribution of $0.0838. 30-Day Sec yield of 0.29% (as of 3/16/2016).
    • SPDR MSCI USA Quality Mix ETF (NYSEARCA:QUS) - quarterly distribution of $0.3087. 30-Day Sec yield of 2.09% (as of 3/16/2016).
    • SPDR S&P Telecom ETF (NYSEARCA:XTL) - quarterly distribution of $0.1775. 30-Day Sec yield of 2.16% (as of 3/16/2016).
    • All are payable Mar. 29; for shareholders of record Mar. 22; ex-div Mar. 18.
    | Fri, Mar. 18, 3:16 PM
  • Wed, Jan. 27, 3:30 PM
    • As if biotech investors need reminding, biotechs (and healthcare stocks) are getting some rude treatment today, the market's foul mood notwithstanding. The Nasdaq Composite Index is down 2.5%,but the SPDR S&P Biotech ETF (XBI -4.7%) almost twice as much. The iShares Nasdaq Biotechnology ETF (IBB -3.5%) is faring a bit better, but still down more than the broad market.
    • Only Biogen and Abbott have bucked the trend.
    • Sample of tickers: (AMGN -2.5%)(BIIB +5.7%)(CELG -3.9%)(GILD -3.3%)(ALXN -1.2%)(ABT +0.3%)(BMY -1.8%)(MRK -3%)(VRX -4%)(PFE -0.9%)
    • ETFs: BIB, BIS, CNCR
    | Wed, Jan. 27, 3:30 PM | 63 Comments
  • Wed, Jan. 20, 1:47 PM
    • It appears that biotech investors have had enough of the sidelines. Many tickers are showing bullish reversals.
    • Representative tickers: (RLYP +15.3%)(CELG +2.6%)(AMGN +0.2%)(BIIB -1.6%)(ALXN -0.6%)(VRTX +0.2%)(IBB +0.8%)(XBI +2.1%)
    | Wed, Jan. 20, 1:47 PM | 20 Comments
  • Dec. 18, 2015, 5:48 PM
    • SPDR S&P Biotech ETF (NYSEARCA:XBI) announces quarterly distribution of $0.1487.
    • 30-Day Sec yield of 0.49% (as of 12/17/2015).
    • Payable Dec. 29; for shareholders of record Dec. 22; ex-div Dec. 18.
    | Dec. 18, 2015, 5:48 PM
  • Oct. 26, 2015, 11:39 AM
    • It's been a "remarkable turn" in relative performance, says Deutsche Bank's David Bianco, noting health care was about 1K basis points ahead of the S&P 500 as recently as mid-August, but both are now about flat and neck-and-neck year-to-date.
      "We find this reversal unwarranted and think health care could surge into year-end," says Bianco, and if the move doesn't come in 2015, it'll surely happen next year. As for valuation, health care is selling for 14.7x 2016E EPS vs. the S&P 500 at 16x - this even as health care's expected 6% sales growth should easily trump that of nominal GDP and the S&P 500. Biano sees 6-9% EPS growth, also better than the S&P.
    • Focus on the big picture, says Bianco: "We believe growth in health care products will stay strong owing to an aging population and increasing efforts to treat conditions with drugs and maximize the productivity of scarce healthcare labor with as many tools and conveniences as conceivable." He likes S&P 500 biotech, pharma, devices, equipment, supplies, tech, and tools, but is cautious on managed care and other healthcare services and facilities.
    • ETFs: IBB, IYH, XLV, XBI, VHT, PJP, BBH, FBT, HQH, CURE, XPH, HQL, PBE, FXH, RXL, IHE, FHLC, SBIO, IHF, PPH, IHI, XHS, RYH, BBC, THQ, PSCH, BBP, XHE, RXD, CNCR, LABD, LABU, UBIO, ZBIO
    | Oct. 26, 2015, 11:39 AM | 18 Comments
  • Oct. 15, 2015, 10:44 AM
    • The first of its kind, the Loncar Cancer Immunotherapy ETF (Pending:CNCR) launches, tracking an index developed by biotech investor Brad Loncar. The expense ratio is 0.79%.
    • Among the names held are Bristol-Myers Squibb, Merck, Juno Therapeutics, and Cellectis. Total holdings number 30.
    • Related ETFs: IBB, XBI, BBH, FBT, HQL, PBE, SBIO, BBC, BBP, LABD, UBIO, LABU, ZBIO
    | Oct. 15, 2015, 10:44 AM | 11 Comments
  • Oct. 13, 2015, 3:49 PM
    • Getting out in front of what should be more bashing of their business models at the Democratic debate tonight, the healthcare names (XLV -1.3%) have about doubled the decline in the S&P 500. Within healthcare, it's the biotechs (IBB -3.1%) and pharmaceuticals (XPH -3.2%) leading the way south.
    • Celgene (CELG -3.3%), Biogen (BIIB -3.6%), Amgen (AMGN -3.5%), Allergan (AGN -4.1%), Mylan (MYL -3.6%)
    • The biotech heavy Russell 2000 (IWM -1.4%) is feeling the pain as well.
    • ETFs: IBB, IYH, XLV, XBI, VHT, PJP, BBH, FBT, HQH, CURE, XPH, HQL, PBE, FXH, RXL, IHE, FHLC, SBIO, PPH, RYH, BBC, THQ, BBP, RXD, LABU, LABD, UBIO, ZBIO
    | Oct. 13, 2015, 3:49 PM | 27 Comments
  • Sep. 27, 2015, 8:59 AM
    • The $8B iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) fell 4.9% on Friday and 13% for the week - its worst weekly performance since the height of the financial panic seven years ago. Many biotech ETFs eat the same cooking - Gilead (NASDAQ:GILD), Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), and Regeneron (NASDAQ:REGN) among the popular names - and FBT, XBI, and BBP fell in amounts similar to IBB.
    • The news flow was relatively quiet late in the week, but Hilary Clinton's promise Monday to clamp down on drug prices set things in negative motion for the momo sector.
    • Barron's Chris Dieterich reminds that a flood of biotech IPOs in recent years has filled the small cap universe with these highly speculative names, and biotech now makes up 7% of the iShares Russell 2000 Index (NYSEARCA:IWM). Indeed. The IWM fell 3.7% for the week, nearly tripling the decline of the S&P 500.
    • ETFs: IWM, TZA, TNA, UWM, VB, VBK, URTY, SCHA, TWM, IWO, RWM, SRTY, VTWO, RCG, JKJ, VTWG, TWOK, FYX, JKK, EWRS, ZSML, FYC, SMLL, RYRSX
    | Sep. 27, 2015, 8:59 AM | 127 Comments
ETF Hub
Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub